跳至主要内容
临床试验/IRCT20240527061909N1
IRCT20240527061909N1招募中3 期

Investigation of the efficacy of Risperidone in the treatment of developmental stuttering in Persian-speaking children aged 5 to 10 years

Babol University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 10 years(—)
性别
All

入选标准

  • 1. Age range from 5 to 10 years
  • 2. Having a diagnosis of developmental stuttering disorder based on the score of the SSI-3 test and the therapist's speech diagnosis
  • 3. Absence of any language, speech or reading disorders other than stuttering
  • 4. Absence of any kind of neurological, movement, vision, hearing, mental-cognitive problems in the past or present
  • 5. Not taking drugs affecting cognitive function or stuttering, in the last month or during research
  • 6. Absence of history of speech therapy treatment at least in the last 3 months

排除标准

  • The individual's unwillingness to cooperate in any stage of the research.

研究者

相似试验